Review Article
Bone Loss Prevention of Bisphosphonates in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Table 2
Summary of the number of adverse events, nonvertebral and vertebral fractures between the bisphosphonate and control groups.
| Trial | Year | Bisphosphonate group | Control group | Number of patients | Number of adverse events | Number of nonvertebral fractures | Number of vertebral fractures | Number of patients | Number of adverse events | Number of nonvertebral fractures | Number of vertebral fractures |
| Bartram et al. | 2003 | 37 | 4 | | | 37 | 3 | | | Haderslev et al. | 2000 | 15 | 12 | 0 | 1 | 17 | 13 | 1 | 2 | Siffledeen et al. | 2005 | 71 | 5 | | 1 | 72 | 2 | | 0 | Soo et al. | 2012 | 45 | 2 | | | 43 | 3 | | | Tirpitz et al. | 2003 | 35 | 9 | | | 13 | 3 | | | Klaus et al. | 2011 | 54 | 12 | | 0 | 32 | 9 | | 1 | Henderson et al. | 2006 | 30 | 18 | 1 | | 31 | 19 | 1 | | Palomba et al. | 2005 | 45 | 5 | 0 | 5 | 45 | 2 | 4 | 14 | van Bodegraven et al. | 2014 | 64 | 0 | | 0 | 67 | 1 | | 1 | Abitbol et al. | 2007 | 33 | 26 | | | 34 | 24 | | | Kitazaki et al. | 2009 | 19 | 3 | | | 20 | 1 | | |
|
|